Skip to main content
OpenTrials
Completed

NCT Number: NCT04965142

Feasibility of a Home Exercise Program to Manage Post-transplant Metabolic Syndrome

Post-transplant metabolic syndrome (PTMS) affects about 50% liver transplant (OLT) and 25% lung transplant (LTx) recipients at 12-18 months post-transplant. PTMS (comprised of glucose intolerance, obesity, hypercholesterolemia and hypertension) has been associated with increased risk for cardiovascular morbidity and long-term survival. Exercise studies in the early post-transplant period have shown some benefits on PTMS risk factors with facility-based training, but it remains unclear if exercise can be sustained in the home environment with sufficient adherence or training intensity to impact PTMS beyond the early post-transplant period. Objectives: 1) To evaluate the feasibility of a three-month individualized, virtual home-based exercise training program in OLT and LTx recipients starting at 1 year post-transplant. 2) To assess estimates of intervention efficacy on elements of PTMS, insulin resistance, exercise self-efficacy, and health related quality of life (HRQL). Methods: 20 OLT and 20 LTx recipients with 2 or more PTMS risk factors at 12-18 months post-transplant will be randomized to a home-based exercise program versus usual care. The exercise group will undergo aerobic training 3 to 5 times per week with resistance training at least twice weekly over a 12-week period. Exercises will be demonstrated by a qualified exercise professional during the first visit with weekly phone and video calls to guide exercise progression, ease communication and promote exercise self-efficacy and adherence based on guiding behavioral principles. As secondary measures, PTMS, insulin resistance, body composition (optional), HRQL, and assessment of self-efficacy will be assessed at baseline and 12-weeks.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Metabolic Syndrome Glucose Metabolism Disorders Hyperinsulinism Insulin Resistance Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Health Network - Toronto General Hospital

Toronto, Ontario, M5G 2C4, Canada

About this study

Both LTx and OLT recipients have several common risk factors for PTMS including significant weight gain, immunosuppression, and physical inactivity. These risk factors have been shown to be partly reversible with an active lifestyle. A home-based exercise program may prove to be an effective post-transplant intervention for improving the metabolic profile of transplant recipients.

Primary objective: To evaluate the feasibility (recruitment rate, program adherence, attrition, safety, and participant satisfaction) of a 12 week individualized, virtual home-based aerobic and resistance training program in OLT and LTx recipients that are 12-18 months post-transplant. Secondary objective: To assess estimates of intervention efficacy on elements of PTMS, insulin resistance, exercise self-efficacy, and HRQL.

Hypotheses: We hypothesize that it will be feasible to recruit both OLT and LTx recipients into a home-based exercise program with ≥ 70% adherence to the prescribed exercise dose. Secondary Objective: PTMS risk factors, self-efficacy and HRQL will be improved with a home-based exercise program.

The home-based exercise group will be asked to exercise 3 to 5 times per week (≥ 150 minutes of aerobic exercises at moderate intensity) and to also complete resistance training (resistance bands or free weights) over a 12-week period with the guidance of a qualified exercise professional. The control group will be counselled by a qualified exercise professional on the importance of accumulating at least 150 minutes of moderate physical activity during the first assessment at the beginning of the study. Both groups will also receive physical activity trackers (Fitbit), exercise training or physical activity logs, and a counselling session by the dietitian at the start of the study.

A home-based exercise program may prove to be an effective post-transplant intervention for improving the metabolic profile of transplant recipients. Characterizing the feasibility, adherence, and effect estimates of home-based exercise training constitutes the first key step in promoting a healthy lifestyle in transplant recipients, and supporting the development of future trials aimed at reducing the morbidity associated with PTMS.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult lung and liver transplant recipients 12 to 18 months post-transplant
  • Presence of 2 or more metabolic risk factors (hypertension, hyperlipidemia, diabetes, obesity)

Exclusion criteria

  • Active cardiovascular disease (recent heart attack, significant coronary artery disease on cardiac catheterization, heart failure, uncontrolled arrhythmias, chest pain, dizziness, or fainting in the last 3 months)
  • Neuro-muscular disease or orthopedic limitations
  • Physically active with ≥ 150 minutes/week of moderate-intensity aerobic physical activity
  • Residing outside the province of Ontario

Treatment and study plan

Exercise Training

Behavioral

The intervention group will be asked to complete aerobic exercises 3 to 5 times per week (≥ 150 minutes of at least moderate aerobic intensity) and resistance training at least twice a week over a 12-week period.

Primary outcomes

  1. Recruitment

    Time frame: When recruitment is complete (approximately 18 months after study initiation)

    We will measure recruitment-success percentage and will record reasons for non-participation.

  2. Adherence to Exercise Training

    Time frame: Over a 12 week period

    Adherence to the home-based exercise program (aerobic and resistance) will be measured through an exercise diary completed by participants and reviewed through weekly communication.

  3. Study Retention

    Time frame: Over a 12 week period

    Retention will be assessed by measuring attrition throughout the intervention period.

  4. Adverse Events During Exercise Training (Safety and Tolerability)

    Time frame: Over a 12 week period

    Adverse events with exercise training will be assessed throughout the study period.

  5. Participant Satisfaction with Exercise Training and Study Participation (Exercise Group)

    Time frame: Change over the study period assessed at weeks 2, 6, and 12

    Multiple choice and free form questionnaire assessing the participants' satisfaction with the home exercise program and study intervention.

  6. Participant Satisfaction with Study Participation (Control Group)

    Time frame: 12 weeks from baseline assessment

    Multiple choice and free form questionnaire assessing participants' satisfaction with the study intervention.

Secondary outcomes

  1. Total Cholesterol

    Time frame: Change from baseline at 12 weeks

    Participants will undergo fasting blood work to assess total cholesterol levels.

  2. Triglycerides

    Time frame: Change from baseline at 12 weeks

    Participants will undergo fasting blood work to assess triglyceride levels.

  3. High Density Lipoprotein

    Time frame: Change from baseline at 12 weeks

    Participants will undergo fasting blood work to assess high density lipoprotein.

  4. Low Density Lipoprotein

    Time frame: Change from baseline at 12 weeks

    Participants will undergo fasting blood work to assess low density lipoprotein.

  5. Fasting Blood Glucose Levels

    Time frame: Change from baseline at 12 weeks

    Fasting blood glucose levels will be ascertained from blood testing results.

  6. Hemoglobin A1C

    Time frame: Change from baseline at 12 weeks

    Hemoglobin A1C results will be assessed from bloodwork, which allows assessment of the average level of blood sugar over the previous 3 months.

  7. Insulin Resistance

    Time frame: Change from baseline at 12 weeks

    Insulin resistance will be captured using the Homeostatic Model Assessment of Insulin Resistance protocol (fasting insulin * fasting blood glucose).

  8. C-peptide Levels

    Time frame: Change from baseline at 12 weeks

    C-peptide levels will be analyzed via blood testing in a subset of participants on exogenous insulin therapy.

  9. C-reactive Protein Levels

    Time frame: Change from baseline at 12 weeks

    C-reactive protein levels will be ascertained from blood testing results.

  10. Health Related Quality of Life assessed with the Short-Form 36 Health Survey

    Time frame: Change from baseline at 12 weeks

    The Short-Form 36 Health Survey (SF-36) will be used to assess general health-related quality of life. The SF-36 consists of eight scaled scores (total score ranging from 0 to 100), with lower scores representing lower health-related quality of life.

  11. Physical Function assessed with the Short-Physical Performance Battery

    Time frame: Change from baseline at 12 weeks

    The Short-Physical Performance Battery will assess participants' balance, gait speed, and ability to rise from a chair 5 times.

  12. Physical Activity Questionnaire

    Time frame: Change from baseline at 12 weeks

    The Physical Activity Scale for the Elderly (PASE) is a short survey created to assess physical activity levels in older adults. The PASE uses frequency, duration, and intensity level of physical activities over one week to assign a score (ranging from 0 to 793), with higher scores indicating greater levels of physical activity.

  13. Self-Efficacy with Exercise Training (Exercise Group)

    Time frame: Change from baseline at 2, 6, and 12 weeks

    The Exercise Self-Efficacy Scale (ESES) is a 4-point rating Likert scale in which participants rate their confidence with carrying out their regular physical activities and exercise. The ESES uses a 100-point percentage scale, ranging from 0% (not at all confident) to 100% (highly confident). Higher scores represent higher self-efficacy to exercise.

  14. Self-Efficacy with Exercise Training (Control Group)

    Time frame: Change from baseline at 12 weeks

    The Exercise Self-Efficacy Scale (ESES) is a 4-point rating Likert scale in which participants rate their confidence with carrying out their regular physical activities and exercise. The ESES uses a 100-point percentage scale, ranging from 0% (not at all confident) to 100% (highly confident). Higher scores represent higher self-efficacy to exercise.

  15. Nutritional Questionnaire

    Time frame: Change from baseline at 12 weeks

    The Rapid Eating and Activity Assessment for Patients (REAP) survey assesses nutrient intake and helps with lifestyle counseling. The survey contains 27 questions with higher scores indicating higher diet quality (score range, 27 to 81).

  16. Lifestyle and Environmental Questionnaire

    Time frame: Baseline

    The Lifestyle and Environmental Questionnaire is a questionnaire developed by our research team to assess familiarity and comfort levels surrounding technology, barriers to exercise and assess previous experience with exercise. It is composed of 10 multiple-choice questions with each question assessed independently.

Other outcomes

  1. Liver Fibrosis

    Time frame: Change from baseline at 12 weeks

    A liver Fibroscan (transient elastography) assessment will be performed in a subset of liver transplant recipients to assess the degree of liver fibrosis (thickening/scarring of tissues). The fibrosis result is measured in kilopascals (kPa). This test is optional for study participants.

  2. Fat Free Mass Index

    Time frame: Change from baseline at 12 weeks

    Fat-free mass index will be evaluated using bioelectrical impedance. This test is optional for study participants.

  3. Body Fat Mass Index

    Time frame: Change from baseline at 12 weeks

    Body Fat Mass Index will be evaluated using bioelectrical impedance. This test is optional for study participants.

  4. Electrocardiogram

    Time frame: Baseline

    12 Lead Electrocardiogram will be performed in all study participants. The following electrocardiogram parameters (p wave, QRS complex, QT interval, T waves, and ST segments) will be assessed to ensure they are within normal limits before starting exercise program.

Sponsors and collaborators

Lead sponsor

University Health Network, Toronto

Other

Collaborators

  • Canadian National Transplant Research Program
  • University of Toronto

Registry information

Official study title

Feasibility of a Home-Based Exercise Program in Lung and Liver Transplant Recipients for Management of Post-Transplant Metabolic Syndrome: a Pilot Randomized Controlled Trial

Important dates

Study start
2021
Primary completion
2024
Study completion
2024
First posted
Jul 16, 2021
Registry last updated
Nov 26, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.